Fedwatch: How Few i...
Basic Materials: Chemicals
ChromaDex Corporation (CDXC: OTC)
$0.82 0.04 | 4.46%
06/18/13 - 03:57 PM ET
392.98K / 304.80K
Vol / Avg. Vol:0.77 / 0.78
Open / Prev. Close:0.65 - 0.82
Today's Range:0.50 - 1.25
52 Wk Range:27.27%
Performance YTD:TheStreet Rating:
Portfolios with CDXC
- Portfolio NameUser Type
- UserStan/Gino
Latest CDXC Headlines from TheStreet
- Insiders Trading CDXC, IHS, HFC, MWIV 06.22.12 | 09:06 am
Press Releases for CDXC
- ChromaDex® Initiates First Human Clinical Study For Its New Caffeine Ingredient Technology, PURENERGY⿢ - PR Newswire 04.18.13 | 05:04 am
- ChromaDex® CEO To Chair Conference Session On Quality Control For Dietary Supplements - PR Newswire 04.15.13 | 05:04 am
- ChromaDex® Introduces New Caffeine Ingredient Technology, PURENERGY⿢ - PR Newswire 04.01.13 | 05:04 am
- Dr. Nancy Booth Of Spherix Consulting - A Division Of ChromaDex® - Appointed To American Botanical Council Advisory Board - PR Newswire 03.21.13 | 05:03 am
- ChromaDex® To Present At 25th Annual ROTH Conference On March 19, 2013 - PR Newswire 03.13.13 | 05:03 am
- ChromaDex® Adds To Its Exclusive Worldwide Patent Rights For Nicotinamide Riboside (NR) With Washington University Agreement - PR Newswire 03.08.13 | 06:03 am
- ChromaDex® To Distribute LoGiCal®, A New Range Of Reference Standards In The United States - PR Newswire 02.07.13 | 05:02 am
- ChromaDex® To Distribute IsoLife Stable Isotope Labeled Phytochemicals And Plant Products - PR Newswire 01.22.13 | 05:01 am
- ChromaDex® To Present At The RedChip Small-Cap Virtual Conference On December 5th At 2:45 P.m. EST - PR Newswire 12.04.12 | 05:12 am
- ChromaDex® Acquires Spherix Consulting - PR Newswire 12.03.12 | 05:12 am
Partner Headlines for CDXC
